REPLIDYNE INC 4
4 · REPLIDYNE INC · Filed Jun 15, 2007
Insider Transaction Report
Form 4
REPLIDYNE INCRDYN
EARL CHRISTOPHER
Director
Transactions
- Award
Stock option (right to buy)
2007-05-10+8,156→ 8,156 total(indirect: See footnote)Exercise: $5.46From: 2008-05-10Exp: 2017-05-10→ Common Stock (8,156 underlying)
Footnotes (2)
- [F1]Automatic grant to Reporting Person of a stock option. Option vests as follows: 100% of the shares vest one year after the date of grant. The option expires ten years after the date of grant.
- [F2]These options are held for the benefit of an entity controlled by affiliates of Perseus-Soros BioPharmaceutical Fund, LP, of which Mr. Earl is a senior advisor.